Mapping Of The Responsible Investments Instruments In Sdg 3 ‘Good Health And Well-Being’ Financing: EU And US Experience

Abstract

This article summarizes the existing approaches to investigating instruments of responsible investments in the health care system in Europe and in United States. The main research’s purpose is to identify existing instruments of responsible investment under funding Sustainable Development Goal 3: ‘Good health and well-being’. Systematization of scientific sources and approaches on the investigated issue showed no unique approach to forming a list of responsible investment instruments to finance health and well-being in Europe and United States. Hence, existing approaches vary by risk, return, suitability for financing, and so on. Therefore, the analysis and generalization of existing approaches and investigating their implementation-related practical features are the relevant scientific problem. The research’s object is the health care financing approaches of the generally recognized organizations such as the Financial Initiative for Biodiversity under the United Nations Development Program, the United States Agency for International Development and the World Bank (Biodiversity Finance Initiative United Nation Development Program, USAID, World Bank). The authors noted that these organizations contributed greatly to provide funding for these projects at the global level. For gaining the research’s goal, this study was conducted in the following logical sequence. Firstly, the authors characterized the Biofin financial decisions in health care under the United Nations Development Program. Secondly, the study systematized the U.S. Agency for International Development financing approaches regarding the Sustainable Development Goal 3. Then, the authors generalized the practical directions towards realizing the mentioned above instruments while digging into the World Bank responsible investment activity regarding health care. The study suggested the typology method to identify the key criteria for classifying responsible investment instruments. In turn, the mapping method was used to generalize the scientific background concerning health care finance. Therefore, the findings could help scientists further develop and unify the classification of responsible investment instruments regarding sustainable development and health care financing based on EU and US experience. Moreover, the obtained results enrich the existing global approaches in funding the national health care system and reaching the established Sustainable Development Goals 3 ‘Good health and well-being’.

Quality of scientific activity as a determinant of socio-economic development

“…Undoubtedly, when opening own business, you may encounter many traditional obstacles, for example, capital limitations and the search for additional investments, business partners and lack of confidence in opening a new business, risks related to the competitors' activities in a particular business environment. However, all mentioned factors set the tone for readiness to be an active participant in the business environment (Serpeninova et al, 2020). It is important to understand the ability to adapt educational services to the requirements of the modern labor market (Delibasic et al, 2022;Zuluaga-Ortiz et al, 2022;Draskovic et al, 2020;Hitka et al, 2021).…”

Foreign direct investment and shadow economy: One-way effect or multiple-way causality?

“…Nowadays, there is no unified understanding of the role of the shadow economy in the functioning of the economy and ensuring its stability. According to the results of the paper's analysis, it can be concluded that the shadow economy negatively affects certain sectors of economic development and the attractiveness of Lithuania (Ginevicius et al, 2021), Ukraine (Kuznyetsova et al, 2017;Shpak et al, 2022), Algeria (Ramli et al, 2022), EU countries (Roszko-Wójtowicz & Grzelak, 2020;Serpeninova et al, 2020;Vasanicova et al, 2022), Croatia (Škare et al, 2020), BRICS (Cheteni, P. & Umejesi, 2022;Tsaurai, 2022); Central Asia and Eastern Europe (Kaya & Engkuchik, 2021).…”

Influence of Monetary Policy Instruments and Indicators on Dynamics of Financing Innovation: Empirical Evidence

“…Conversely, if tax credits are the main incentive, firms reduce (increase) their share of R&D expenditures while strengthening (weakening) credit [1]. Kobushko et al (2017) [2], Sineviciene et al (2018) [3], Miuller, Kuznetsova et al (2021) [4], Serpeninova et al (2020) [5] investigated promoting and financing innovation to increase the economic growth, security and sustainable development. Gil & Iglésias (2020) determined the long-term effects of inflation and monetary policy in the growth model, including indicators of R&D, real interest rate, economic growth, investment rate etc.…”